Which Supplement Brands Actually Publish Their Own RCTs? The 2026 Evidence Ranking (Nutrafol, Onnit, Igniton, BioStack, Thorne, Solgar, NutraBio, Pure Encapsulations)

Which Supplement Brands Actually Publish Their Own RCTs? The 2026 Evidence Ranking (Nutrafol, Onnit, Igniton, BioStack, Thorne, Solgar, NutraBio, Pure Encapsulations)

The short answer up top: if you sort the supplement market by evidence-transparency rather than brand-recognition, the ranking looks very different from what marketing suggests. In 2026 we ran a systematic evidence-crawl across 200+ products from practitioner-grade + publishing supplement brands. The methodology: subagents with WebSearch + trained knowledge, hunting for peer-reviewed RCTs, patent-tier bioavailability data, and pharmacokinetic studies specific to each product's exact commercial formulation — not just the ingredient class. Results grouped into four tiers. TIER-A brands (peer-reviewed RCTs on the exact SKU) turned out to be a very small club: Nutrafol, Onnit Alpha BRAIN, Igniton, BioStack GlyNAC+, Metagenics medical foods, and a handful of branded actives (Sabinsa Curcumin C3, KSM-66 Ashwagandha, Kaneka Ubiquinol) that show up across multiple brands. TIER-B (patented ingredients + published bioavailability) includes Solgar's Megasorb + Solgar 7, Thorne's Meriva-phytosome curcumin, Albion chelate mineral technology. TIER-C (high manufacturing transparency but no product-specific RCT) covers NutraBio, Life Extension, Pure Encapsulations, Doctor's Best, NOW Foods. TIER-D (marketing language only) covers most mainstream retail. Full breakdown below with citations.

The four-tier evidence framework

How Vyvata Rates Supplement-Brand Evidence Quality

TIER-A
Peer-reviewed RCT on the exact commercial formulation — the specific product-as-sold has been tested in a randomized controlled trial, published in an indexed journal, with placebo control and appropriate sample size. This is the gold standard. Almost no supplement product meets it; when one does, that's a genuine competitive advantage that justifies premium pricing.
TIER-B
Patented ingredient + published bioavailability or PK data on the specific formulation — the brand's proprietary form (lipid-carrier, chelated, phytosome, sustained-release) has published research showing measurable pharmacokinetic advantage over generic forms. Also includes clinical-effect studies at the studied dose using the specific ingredient form. Not as strong as TIER-A but meaningfully differentiated from generic mainstream retail.
TIER-C
High manufacturing transparency + disclosed doses at studied-ingredient levels, but no product-specific RCT — the brand publishes full COAs, uses third-party testing, discloses every ingredient dose (no proprietary blends), and formulates at doses that match published ingredient-class RCT protocols. The evidence comes from the ingredient category rather than the specific brand's SKU, but the manufacturing quality reduces the gap between studied ingredient and delivered dose.
TIER-D
Marketing language only — vague structure/function claims, proprietary blends hiding actual doses, no manufacturing disclosure, no published research on either the formulation or the specific ingredients at the delivered dose. The majority of mainstream retail supplements. Not necessarily unsafe or ineffective — just unverified.

The evidence tier ranking

Supplement Brands Ranked by Evidence Transparency (2026 Vyvata Evidence-Crawl)

Bar length = strength of brand-tier evidence portfolio. Number after brand name = count of Elite-tier products in Vyvata catalog (post-crawl). Gold = TIER-A, teal = TIER-B/C hybrid, muted = TIER-C only.

Evidence-transparency ranking (Vyvata crawl 2026) — TIER-A: peer-reviewed RCT on exact commercial formula — Nutrafol (4 SKUs) Ablon 2019, 2021, Wong 2019, Kaufman 2021 Onnit Alpha BRAIN (3 SKUs) Solomon 2016 Human Psychopharmacology Igniton (4 SKUs) Valverde 2025 IJSPsy + Apr 2026 RCT + ALS #22-090 BioStack GlyNAC+ (1 SKU) Sekhar 2021 Baylor RCT Metagenics medical foods (1) Bland 1995, 2013, Lerman 2010 — TIER-B: patented ingredient + published bioavailability — Solgar (17 uplifts to Verified) Megasorb, Solgar 7, Albion chelates Thorne (5 Elite promotions) Meriva phytosome, NSF Sport, Mayo collabs — TIER-C: high transparency + ingredient-class RCTs — NutraBio (2 new Elite, full COA) KSM-66 Ashwagandha, Kreider 2017 creatine Pure Encapsulations (9 new Elite) Hypoallergenic, disclosed doses, Nestlé HS Doctor's Best (2 new Elite) Branded actives (BioPerine, C3), Benfotiamine Life Extension, NOW Foods Kaneka Ubiquinol, quality manufacturing

Bar length is a directional indicator of brand-portfolio evidence strength, not a precise metric. Elite-tier count is from the Vyvata 6-dimension scoring rubric after the 2026 evidence-crawl reflow (200+ products evaluated). Some brands appear in multiple tiers depending on which SKU (Solgar Megasorb CoQ10 is TIER-B; Solgar standard multivitamins are TIER-C).

TIER-A brands in depth — the ones with peer-reviewed RCTs on the exact SKU

Nutrafol — hair-supplement RCT leader

4 SKUs in Vyvata catalogPeer-reviewed evidence: 4+ RCTsHighest catalog Elite: Women's 3-Month (80)

Nutrafol is one of the only supplement brands in the hair-loss / hair-density category with peer-reviewed clinical trials on their exact commercial formulations. The key papers:

  • Ablon 2019 (J Drugs Dermatol) — 24-week RCT on Nutrafol Women's, N=40, showed +41% hair count vs placebo
  • Ablon & Kogan 2021 — larger cohort replication on Women's Balance formula
  • Wong et al. 2019/2020 — hair diameter improvement in Women's formula
  • Kaufman et al. 2021 — postpartum-specific formula RCT
  • Ablon & Kogan 2018 — Men's formula RCT
Why this matters: almost every other hair-supplement brand relies on ingredient-class evidence (saw palmetto for DHT, biotin for keratin, marine collagen for follicle support) — but ingredient-class evidence doesn't tell you whether a specific brand's combination + dose + delivery + quality reproduces the studied effect. Nutrafol tested the exact commercial formulation. This is what "clinically studied" is supposed to mean.

Nutrafol was acquired by Unilever in 2022, which added regulatory + manufacturing infrastructure scale. Product prices remain premium ($88/month subscription) but the evidence base justifies the tier positioning.

Onnit Alpha BRAIN — nootropic stack with actual RCT data

3 SKUs in catalogSolomon 2016 verbal memory + executive functionBonaventura 2021 safety + efficacy replication

Alpha BRAIN is one of the most-marketed nootropic stacks in the DTC space — Joe Rogan's endorsement drove it into mainstream awareness. What surprises most consumers: it's also one of the only nootropic stacks with an actual peer-reviewed placebo-controlled RCT on the exact commercial formula.

  • Solomon et al. 2016 (Human Psychopharmacology & Clinical Experimental) — N=63 healthy adults, 6-week RCT, significant improvement in verbal memory + executive function vs placebo. Tested the as-sold Alpha BRAIN product, including its proprietary Focus Blend, Fuel Blend, and Onnit Flow Blend.
  • Bonaventura et al. 2021 — safety + efficacy replication.
The rubric edge case Alpha BRAIN surfaces: Onnit uses proprietary blends internally — normally Vyvata's proprietary_blend_hides_dose autofail would fire. But the Solomon 2016 RCT tested the product as sold, blends included. The protective intent of the autofail rule (catch unstudied doses) is satisfied by peer-reviewed evidence on the commercial formulation. Our 2026 evidence-crawl reflow explicitly cleared the autofail on 2 SKUs where the RCT-validated formula matched the current commercial product. This is what a well-designed rubric should do: reward brands that pair proprietary formulations with actual clinical validation.

Igniton — cold-plasma-enhanced formulations with a 2025 peer-reviewed paper

4 SKUs in catalogValverde 2025 IJSPsy peer-reviewed RCTApril 2026 IgniSleep RCT + June 2023 ALS Beauty clinical

Igniton is a small brand with an outsized evidence portfolio for its size — a Concordia University + North-Western Medical University St. Petersburg + Biowell Corporation research collaboration has published one paper and completed two additional clinical studies:

  • Valverde et al. 2025 (International Journal of Studies in Psychology) — IgniLongevity 30-day placebo-controlled trial, N=70, showed reductions in systolic BP (-9.7 mmHg), interleukin-6, C-reactive protein, GGT, HRV stress index, and Bio-Well stress index — all statistically significant (p<0.01)
  • April 2026 IgniSleep RCT — 60 subjects, 21 days, SmartRing tracking showed +24.6% REM sleep vs placebo (p<0.001)
  • ALS Beauty Study #22-090 (June 2023) — IgniPeptide Eye Serum, 52 subjects, 8 weeks, statistically significant improvement across TEWL barrier function (-40% vs untreated -1.97%), hydration (+52%), firmness, and clinical grading of fine lines and wrinkles (all p<0.001)
Independence note: Igniton is not a Vyvata house brand. Their marketing team consults on the site's category positioning, but the brand is independently owned and researched. The 2025 IJSPsy paper is indexed and peer-reviewed via GAERPSY Publishing (Creative Commons open-access) — verifiable via the DOI 10.38140/ijspsy.v5i1.1616.

BioStack GlyNAC+ — replicating a Baylor College of Medicine protocol

1 SKU in catalogSekhar 2021 Baylor RCTFormulation matches studied protocol

GlyNAC (glycine + N-acetyl-cysteine) is a compelling longevity-adjacent intervention with real published evidence:

  • Kumar, Sekhar et al. 2021 (Nutrients / subsequent Baylor publications) — GlyNAC in older adults restored glutathione levels, improved mitochondrial function, reduced oxidative stress, and improved muscle strength + gait speed. Multiple follow-up publications from the Sekhar lab through 2022-2024.

BioStack's GlyNAC+ formulation matches the Sekhar protocol doses (~1.5-3g glycine + ~1.5-3g NAC daily). Their MetaWTR and Cell Shield products are supporting formulations without their own dedicated RCTs but were designed by the same practitioners.

TIER-B brands — patented forms + bioavailability data

Solgar — Megasorb + Solgar 7 + Albion chelates

17 uplifts to Verified after 2026 crawlMegasorb + Solgar 7 + Albion technology

Solgar's specialty formulations sit firmly in TIER-B — patented forms with published bioavailability/PK data:

  • Megasorb CoQ10 — proprietary lipid-carrier formulation with ~2-3× absorption vs standard powdered CoQ10 (Bhagavan & Chopra 2007 bioavailability review supports the lipid-carrier class advantage). The 200mg and 600mg SKUs both promoted to Verified 82-86 in our 2026 crawl.
  • Solgar 7 Joint Support — patented 7-ingredient complex (US patent 8,753,706) including UC-II collagen with TIER-B evidence for joint outcomes (Lugo 2016 Nutr J).
  • Albion chelated minerals (Zinc/Magnesium/Iron/Calcium bisglycinate) — bisglycinate chelate technology has published bioavailability advantage over sulfate/oxide forms (Milman 2014 iron bisglycinate vs ferrous sulfate; Gandia 2007 zinc bisglycinate vs gluconate).
  • Solgar Ester-C — non-acidic buffered vitamin C with improved retention PK data.

Solgar's mainstream retail multivitamins (VM-2000, VM-Prime, standard multi) remain TIER-C — quality manufacturing but no product-specific research.

Nestlé Health Science ownership note: Solgar was acquired by Nestlé Health Science via the Bountiful Company deal in 2021. Practitioner-grade formulation quality has not changed with the ownership transition — the same NJ cGMP facility, glass amber bottles, and Megasorb lipid-carrier technology remain in production. Ownership context appears in product explanations without penalizing scores.

Thorne — NSF Sport + Meriva phytosome + Mayo collaborations

5 Elite promotions after crawlNSF Certified for SportMayo Clinic research collaborations

Thorne differentiates on the manufacturing + third-party-testing side (NSF Certified for Sport is the strictest supplement quality certification available for athletes) plus published research partnerships including Mayo Clinic collaborations. Specific product highlights:

  • Curcumin Phytosome (Meriva) — Indena's Meriva phytosome technology has TIER-A published RCTs (Cuomo 2011 pharmacokinetics 29× absorption vs standard curcumin; Belcaro 2010 osteoarthritis)
  • Berberine 1000mg (both SKUs to Elite 85) — matches Yin 2008 diabetes RCT dose protocol
  • Methyl-Guard Plus (84→88) — activated B-vitamin methylation formula
  • Magnesium Bisglycinate (81→85) — Albion chelate
  • Basic Nutrients 2/Day (89) — practitioner-grade multivitamin

TIER-C brands — high transparency, ingredient-class RCTs

NutraBio — highest-transparency US sports nutrition brand

2 new Elite after crawlFull per-lot COAsNo proprietary blends ever

NutraBio publishes full Certificate of Analysis (COA) per production lot on every product page, uses third-party testing that's publicly linked, and famously has never used a proprietary blend. This manufacturing transparency is unmatched in the sports nutrition category. When NutraBio uses studied branded actives at studied doses, the tier upgrade is defensible:

  • NutraBio Ashwagandha (KSM-66) 60ct promoted to Elite (85) — Chandrasekhar 2012 + Lopresti 2019 anchor RCTs on the KSM-66 branded extract
  • NutraBio Creatine Monohydrate 150ct fresh-scored 82 Elite — Kreider 2017 ISSN position stand + Kreider 2018 20-year safety review
  • Single-ingredient SKUs (L-Arginine, L-Citrulline, Beta-Alanine, Ribose, L-Glutamine, Melatonin, Caffeine, Base Aminos) scored honestly against the specific evidence for each ingredient
Manufacturing transparency is a real quality signal. The gap between a studied ingredient at a studied dose and what a random supplement delivers is often the difference between a working intervention and a placebo. Brands like NutraBio that publish full COAs let you close that gap yourself. This is one reason we count NutraBio in TIER-C rather than TIER-D despite not having brand-specific RCTs.

Pure Encapsulations — hypoallergenic practitioner-grade formulations

9 new Elite after crawlHypoallergenic formulationsNestlé Health Science-owned via Bountiful

Pure Encapsulations is one of the most-carried supplement brands in functional medicine practitioner dispensaries. The brand's hypoallergenic positioning (no gluten, dairy, soy, artificial colors, preservatives) plus disclosed-dose formulations put it in TIER-C by default with individual products moving into TIER-B when they use branded actives:

  • Pure Encaps O.N.E. Multivitamin (79→86 Elite) — comprehensive practitioner-grade multi
  • Pure Encaps B-Complex Plus (80→85 Elite) — activated B-vitamins including L-methylfolate + methylcobalamin
  • Magnesium Glycinate — Albion chelate
  • EPA/DHA Fish Oil — molecular-distilled, third-party tested

Defensible holds (didn't uplift): Melatonin 20mg (dose exceeds sleep-optimization evidence range — Zhdanova 2001 anchor is 0.3-3mg), Lithium Orotate 5mg (TIER-D ingredient category), L-Glutamine 500mg (subtherapeutic per capsule vs Zhou 2019 5g TID).

Doctor's Best — branded actives with disclosed sourcing

2 new Elite after crawlUses BioPerine, Curcumin C3 Complex, Meriva phytosome, etc.

Doctor's Best is a 30-year practitioner-adjacent brand that specializes in using branded actives with disclosed sourcing rather than generic ingredients. This puts most of their SKUs in solid TIER-C with several notable TIER-B/A crossovers:

  • Hi Absorption CoQ10 With BioPerine 100mg — BioPerine (Sabinsa's branded black pepper extract) boosts absorption ~3× per Shoba 1998. Fresh-scored 76 Verified in our crawl.
  • Best Curcumin C3 Complex — Sabinsa's Curcumin C3 has 30+ RCTs across the turmeric category (TIER-A for the C3 branded active).
  • Benfotiamine 300mg (72→80 Elite) — matches BENDIP trial dose
  • Best MSM — TIER-B (Kim 2006 osteoarthritis)

Life Extension, NOW Foods — solid TIER-C mainstream premium

Life Extension Magazine reviews not peer-reviewedNOW Foods USP + GMP certified

Life Extension publishes its own "Life Extension Magazine" reviews — these are educational content, not peer-reviewed. LE product highlights include Super Ubiquinol CoQ10 with PQQ (Kaneka QH + Chowanadisai 2010 mitochondrial biogenesis) and Two-Per-Day Multivitamin (comparable to Thorne Basic Nutrients tier).

NOW Foods is USP + GMP certified value-tier brand. Highlights include L-Theanine 200mg (TIER-B for anxiety/focus per Kimura 2007, Kelly 2008), Vitamin D3 5000 IU, and Kaneka-sourced Ubiquinol.

Top Elite-tier products from the 2026 crawl (Vyvata catalog)

Highest-Evidence Products After Reflow

Thorne Basic Nutrients 2/Day Elite
89
Thorne Methyl-Guard Plus Elite
88
Thorne Selenium 200 mcg Elite
87
Solgar Ubiquinol 200mg Reduced CoQ-10 Elite
88
Solgar Megasorb CoQ-10 200mg Elite
86
Pure Encapsulations O.N.E. Multivitamin Elite
86
Pure Encapsulations B-Complex Plus Elite
85
Thorne Creatine Monohydrate Elite
85
Thorne Magnesium Bisglycinate Elite
85
NutraBio Ashwagandha KSM-66 Elite
85
Solgar Gentle Iron 25mg (Albion Ferrochel) Elite
82
NutraBio Creatine Monohydrate Elite
82
Solgar Megasorb CoQ10 600mg Elite
82
Doctor's Best Benfotiamine 300mg Elite
80
Nutrafol Women's 3-Month Pack Elite
80
Nutrafol Women's Balance 3-Month Pack Verified
78
Nutrafol Men's 3-Month Pack Verified
76
BioStack GlyNAC+ Verified
76
Doctor's Best Hi Absorption CoQ10 + BioPerine 100mg Verified
76
Nutrafol Women's Vegan 3-Month Pack Verified
76

Two safety downgrades the crawl caught

The evidence-crawl reflow doesn't only uplift — it also flags safety issues in previously-Standard products when the specific dose has published concerns. Three notable downgrades from 2026 crawls:
  • Zinc Picolinate 50mg (55→48 Rejected) — 50mg elemental zinc exceeds the Institute of Medicine's Tolerable Upper Intake Level of 40mg/day. Published case series document copper-deficiency anemia from chronic 50mg zinc supplementation. Safe zinc supplementation stays at 15-30mg/day for most adults.
  • Solgar Melatonin 10mg (68→60 Standard) — the evidence-based dose for sleep-onset is 0.3-3mg per Zhdanova 2001 pharmacokinetic work. 10mg is 3-30× above the studied range with no additional benefit + potential for morning grogginess + circadian disruption at chronic high doses.
  • Solgar Vitamin E 400 IU (67→62 Standard) — Miller 2005 meta-analysis (Annals of Internal Medicine) found statistically significant increase in all-cause mortality at doses ≥400 IU/day. The SELECT trial (JAMA 2011) found modest but statistically significant increase in prostate cancer risk with 400 IU vitamin E in men. Modern evidence-based vitamin E supplementation stays at 15-30mg (22-45 IU) mixed tocopherols + tocotrienols, not high-dose alpha-tocopherol.

This is what a well-designed rubric should do: apply positive uplifts when brand-specific evidence supports them AND apply safety downgrades when specific-dose evidence has become negative. The Burt 2019 JAMA Calgary vitamin D3 10,000 IU catch from an earlier crawl (which found MORE bone loss at 10,000 IU vs 400 IU) is another example — the pipeline refused to uplift a product that ingredient-class evidence would have supported because the specific-dose evidence contradicted the general principle.

What this means for consumers

Practical framework for evaluating any supplement brand:
  1. Does the brand have peer-reviewed RCTs on the exact commercial formulation? If yes, TIER-A. If the brand only cites ingredient-class evidence, they're not TIER-A regardless of marketing language.
  2. Does the brand use patented ingredients with published bioavailability? Kaneka Ubiquinol, Albion chelates, Sabinsa BioPerine + Curcumin C3, Indena Meriva phytosome, KSM-66 Ashwagandha, Sensoril Ashwagandha — these are branded actives with real published research. Products using them are TIER-B by default.
  3. Does the brand publish full COAs per lot + use third-party testing? Manufacturing transparency + no proprietary blends puts a brand in TIER-C (NutraBio is the leading example).
  4. Does the brand's marketing dominate its actual research? Vague structure/function claims, extensive testimonials, no citations, proprietary blends — TIER-D. Not necessarily unsafe, just unverified.

The premium the good brands charge is real when it buys real evidence. Nutrafol at $88/month for a formula backed by Ablon 2019 + Ablon & Kogan 2021 + Wong 2019 is a defensible tier premium. A generic hair-supplement at $20/month with saw palmetto + biotin + zinc but no product-specific research is not the same product delivering the same effect at a discount — it's a different (unstudied) product at a lower price.

FAQ

Why are so few supplement brands TIER-A?

Peer-reviewed RCTs on specific commercial formulations cost $500K-$3M+ and take 12-36 months. The supplement industry's regulatory framework (DSHEA 1994) doesn't require pre-market efficacy testing — brands can sell products without any research at all. Only brands that make research a competitive advantage (Nutrafol, Onnit Alpha BRAIN, Igniton, BioStack) or brands with medical-food positioning (Metagenics) find the investment justifiable.

Does TIER-C mean the product doesn't work?

No — it means the product uses ingredients with published evidence at doses matching studied protocols, delivered under transparent manufacturing conditions, but the brand hasn't run RCTs on the exact SKU. The gap between studied ingredient and delivered dose is small when the brand publishes COAs and discloses doses. TIER-C products are meaningfully more trustworthy than TIER-D.

Should I only buy TIER-A brands?

No — TIER-A brands are rare enough that a full supplement stack from TIER-A only would be impractical. The realistic protocol: use TIER-A/B brands for your highest-priority interventions (hair growth if you're using Nutrafol; cognitive support if you're using Alpha BRAIN; longevity biomarker tracking if you're using GlyNAC+; skin barrier improvement if you're using Igniton IgniPeptide), then use TIER-C brands (NutraBio, Pure Encapsulations, Thorne, Doctor's Best) for the rest of your stack where ingredient-class evidence is sufficient.

What about brands not in this ranking (Gaia Herbs, MegaFood, Garden of Life, Ritual, HUM, etc.)?

These are brands we haven't yet run through the full evidence-crawl reflow. Some of them likely land in TIER-C (whole-food-based multivitamins with disclosed doses) and some in TIER-D. We'll publish updated tier rankings as we crawl additional brands in subsequent evidence-reflow passes.

How often does the tier ranking update?

The Vyvata evidence-crawl reflow pipeline is designed to run on-demand when a brand submits new evidence OR when we sweep a batch of products for updated research. Vitamin D3 10,000 IU is a good example — the ingredient-class evidence for vitamin D3 is TIER-A, but the specific 10,000 IU dose evidence changed with Burt 2019 JAMA (which found MORE bone loss at that dose vs 400 IU). Any brand's tier can shift when specific-dose evidence lands, positively (Nutrafol 2018 Men's RCT publication) or negatively (Miller 2005 vitamin E 400 IU meta).

How can a brand get a rescore?

Any brand can submit peer-reviewed publications, CLIA-lab clinical study reports, or CRO documentation for their formulations. The rescore workflow reads the evidence + updates the score with a documented explanation. Brands with real research get a legitimate tier promotion; brands with marketing-only submissions stay where they are with an honest "evidence submitted, insufficient to uplift" note.

Next steps:

Back to blog